IDEX Gears Up to Report Q3 Earnings: What's in the Cards?

IDEX CorporationIEX is scheduled to release third-quarter 2026 results on Oct. 28, before market open.

The Zacks Consensus Estimate for third-quarter earnings has remained steady in the past 60 days. The company has an impressive earnings surprise history, having outperformed the consensus estimate in each of the preceding four quarters, the average surprise being 7.7%.

The consensus estimate for revenues is pegged at $919.4 million, indicating an increase of 4.6% from the prior-year quarter's figure. The consensus estimate for adjusted earnings is pinned at $2.23 per share, indicating an increase of 9.9% from the year-ago quarter's number.

Let's see how things have shaped up for IDEX this earnings season.

Factors to Note Ahead of IDEX's Results

The Health & Science Technologies (HST) segment is expected to have benefited from strength in the data center, semiconductor, space and defense markets in the third quarter. The consensus estimate for the HST segment's revenues is pegged at $423 million, indicating an increase of 11% year over year.

An increase in demand for products across the municipal water end market is expected to have aided the Fluid & Metering Technologies (FMT) segment. Higher demand for mining application solutions business is likely to have been a tailwind as well. The consensus estimate for the FMT segment's revenues is pegged at $321 million, indicating growth of 1.3% year over year.

IDEX has remained focused on expanding its product offerings and market presence through buyouts, which is expected to have boosted its top line. In July 2025, the company acquired Micro-LAM, Inc. (Micro-LAM), which expanded IDEX's optics technology offerings. Also, the acquisition of Mott Corp. and its subsidiaries (Mott) in September 2024 expanded the company's expertise in applied materials science technology capabilities across high-value end markets.

However, the Fire & Safety/Diversified Products (FSDP) segment is expected to have put up a weak show due to softness in the dispensing business arising from the unfavorable timing of dispensing projects in emerging markets. However, positive pricing is expected to have provided some relief. The consensus estimate for the segment's revenues is pegged at $182 million, matching the year-ago quarter figure.

The escalating costs and operating expenses, due to increasing employee-related costs and professional services spending, are likely to have weighed on IEX's bottom line in the to-be-reported quarter.

IDEX Corporation Price and EPS Surprise